China’s State Council Unveils Five-Year Plan to Enhance Urbanization and Address “Three Rural Issues”
The State Council of China has released a “Five Year Action Plan for Deepening the...
Policy / Regulatory
Shanghai Aims to Become Capital Market Hub for High-Quality Science and Innovation Companies
The Shanghai municipal government has unveiled a comprehensive set of measures designed to enhance the...
NICE and AstraZeneca Fail to Reach Agreement on Enhertu Reimbursement for NHS
The UK’s National Institute for Health and Care Excellence (NICE) has announced that negotiations with...
Shanghai Unveils Comprehensive Measures to Strengthen Biopharmaceutical Industry
The Shanghai municipal government has issued a comprehensive set of measures aimed at bolstering the...
China’s NHSA and NHC to Integrate Village Clinics into Basic Medical Insurance System
The National Healthcare Security Administration (NHSA) and the National Health Commission (NHC) of China have...
China’s NMPA Approves Pilot Plan to Streamline Clinical Trial Reviews for Innovative Drugs
In a meeting chaired by Party Secretary and Director of the National Medical Products Administration...
China’s NMPA Issues Guidelines for Onsite Inspections of Medical Device Companies
The National Medical Products Administration (NMPA) of China has released the “Guidelines for Onsite Inspection...
China’s H1 2024 Pharmaceutical Trade Data Indicates Mixed Performance in Global Markets
The Ministry of Industry and Information Technology (MIIT) has released a report on the first...
China’s NHC Reports 2023 County Hospital Medical Service Capability Evaluation Results
The National Health Commission (NHC) of China has released a notice detailing the results of...
Yipinhong Pharmacy Repays $36.7 Million in Bromhexine Marketing Settlement
Yipinhong Pharmacy Co., Ltd (SHE: 300723), a China-based pharmaceutical company, has made a significant repayment...
China Unveils Comprehensive 2030 Plan to Combat Diabetes
China’s National Health Commission (NHC), in collaboration with 12 other ministries, has unveiled the ‘Health...
NHSA Report: China’s Medical Insurance Fund Records Significant Growth and Savings in 2023
The National Healthcare Security Administration (NHSA) has released its comprehensive annual statistical report for the...
China’s NMPA Suspends Daewoong Bio’s Antibiotic, Excludes Firm from National Procurement Program
The National Medical Products Administration (NMPA) in China has taken a decisive step to suspend...
China’s NHSA Updates DRG/DIP Payment Reform Program with New Exclusion Mechanisms and Timelines
The National Healthcare Security Administration (NHSA) in China has issued a notification outlining several updates...
WuXi AppTec Spends Over USD 360,000 on US Lobbying Amid Biosecure Act Deliberations
Endpoints News has reported that WuXi AppTec Co., Ltd, (SHA: 603259) a China-based Contract Development...
NMPA Suspends Import and Sale of SAMO S.p.A Knee and Hip Prosthesis Systems
The National Medical Products Administration (NMPA) has issued a notice to suspend the import, sale,...
China’s NMPA and NHC Implement New Rules for Temporary Import of Urgent Medical Devices
The National Medical Products Administration (NMPA) and the National Health Commission have issued the Management...
China Unveils Ambitious Healthcare Reforms at 20th Central Committee Plenary Session
The third plenary session of the 20th Central Committee of the Communist Party of China...
China Issues Ethical Guidelines for Human Genome Editing, Prohibits Germline Editing
China’s Ministry of Science and Technology (MOST) has issued the Ethical Guidelines for Human Genome...
NHSA Mandates Standardized Online Procurement for Injectable Drugs to Ensure Pricing Transparency
The National Healthcare Security Administration (NHSA) has issued a directive to standardize the procurement process...